EVEREST MEDICINES
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia Pacific territories. We strive to be the partner of choice for innovative companies around the world with products that address critical unmet medical needs for patients in the Emerging Market and have a high probability of market approval. The Everest Medicines team has deep expertise and extensive track record of high quality clinical development, regulatory affairs, CMC, business development and operations both in Asia Pacific territories and with leading global pharmaceutical companies.
EVEREST MEDICINES
Social Links:
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.everestmedicines.com
Total Employee:
51+
Status:
Active
Total Funding:
310 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Content Delivery Network Font Awesome Domain Not Resolving Microsoft Exchange Online Office 365 Mail JsDelivr Microsoft Azure DNS
Similar Organizations
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Current Advisors List
Current Employees Featured
Stock Details
Investors List
RA Capital Management
RA Capital Management investment in Series C - Everest Medicines
CBC Group
CBC Group investment in Series C - Everest Medicines
Octagon Capital Partners
Octagon Capital Partners investment in Series C - Everest Medicines
Janchor Partners
Janchor Partners investment in Series C - Everest Medicines
Hillhouse Capital Group
Hillhouse Capital Group investment in Series C - Everest Medicines
Jiashan SDIC
Jiashan SDIC investment in Series C - Everest Medicines
Janus Henderson Investors
Janus Henderson Investors investment in Series C - Everest Medicines
HBM Healthcare Investments AG
HBM Healthcare Investments AG investment in Series C - Everest Medicines
Rock Springs Capital
Rock Springs Capital investment in Series C - Everest Medicines
Decheng Capital
Decheng Capital investment in Series C - Everest Medicines
Key Employee Changes
| Date | New article |
|---|---|
| 2022-08-25 | Everest Medicines Announces the Departure of CEO, Kerry Blanchard |
| 2021-04-15 | Everest Medicines Appoints Jennifer Yang as Chief Scientific Officer |
| 2021-02-18 | Everest Medicines Appoints Kevin Guo as Chief Commercial Officer |
Official Site Inspections
http://www.everestmedicines.com Semrush global rank: 4.34 M Semrush visits lastest month: 2.63 K
- Host name: 8.218.134.90
- IP address: 8.218.134.90
- Location: Singapore Singapore
- Latitude: 1.2929
- Longitude: 103.8547
- Timezone: Asia/Singapore
- Postal: 18
More informations about "Everest Medicines"
Company Overview – Everest Medicines
Company Overview. Everest Medicines is a Hong Kong-listed (HKEX 1952.HK) biopharmaceutical company focused on discovering, developing, manufacturing and …See details»
Leadership Team – Everest Medicines
Jennifer transitioned into this role from Janssen (China) Research & Development Organization, where she was the head of Discovery Center. Prior to joining Johnson and Johnson, Dr. Yang held global leadership positions at Eli Lilly …See details»
Everest Medicines - Crunchbase Company Profile & Funding
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in the Emerging Market including Asia …See details»
Everest Medicines - LinkedIn
Everest Medicines is dedicated to its mission of developing and commercializing novel transformative pharmaceutical therapies for patients in mainland China and other Asian territories.See details»
Everest Medicines - Overview, News & Similar companies
May 8, 2024 Everest Medicines contact info: Phone number: +86 1065837510 Website: www.everestmedicines.com What does Everest Medicines do? Everest Medicines is a …See details»
Everest Medicines - Products, Competitors, Financials, Employees ...
Oct 9, 2020 Everest Medicines has built a portfolio of potentially global first-in-class or best-in-class molecules in the company's core therapeutic areas of renal diseases, infectious …See details»
Everest Medicines - Craft
Everest Medicines has 5 employees across 4 locations and $761 m in total funding,. See insights on Everest Medicines including office locations, competitors, revenue, financials, executives, …See details»
Everest Medicines Announces New Strategic Plans, Reinforcing ...
For more information, please visit its website at www.everestmedicines.com. For further information, please contact: Investor Relations: Leah Liu, VP Corporate Affairs Everest …See details»
Everest Medicines Announces Strategic Collaboration with …
Jul 20, 2021 For more information, please visit its website at www.everestmedicines.com. About MediTrust Health Co., Ltd. MediTrust is a leading innovative medical payment services …See details»
Everest Medicines Announces Commercial Launch and First …
May 14, 2024 Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing …See details»
Everest Medicines Enters into Agreement with Gilead Sciences for ...
Aug 15, 2022 For more information, please visit its website at www.everestmedicines.com. Forward-Looking Statements: This news release may make statements that constitute forward …See details»
Everest Medicines Commences Operations at its mRNA Vaccine
Dec 28, 2022 For more information, please visit its website at www.everestmedicines.com. Forward-Looking Statements: This news release may make statements that constitute forward …See details»
Everest Medicines' Partner Calliditas Therapeutics Announces U.S.
Mar 12, 2024 For more information, please visit its website at www.everestmedicines.com. Forward-Looking Statements: This news release may make statements that constitute forward …See details»
Everest Medicines, Sinovent and SinoMab Announce Licensing …
Headquartered in Suzhou, China, the Company has established a highly efficient, fully integrated global R&D organization with presence in China, US and Australia. Leveraging our scientific …See details»
Everest Medicines Announces Financial Results for Full Year Ended ...
Dec 31, 2023 Everest Medicines has built a portfolio of first-in-disease or best-in-class products in the Company’s therapeutic areas of interest including renal diseases, infectious diseases, …See details»
Everest Medicines Commences Operations at its mRNA Vaccine ...
Dec 28, 2022 For more information, please visit its website at www.everestmedicines.com. Forward-Looking Statements: This news release may make statements that constitute forward …See details»
Everest Medicines Enters into Comprehensive Agreements with …
For more information, please visit its website at www.everestmedicines.com. About Providence Therapeutics . Providence is a leading Canadian clinical stage biotechnology company …See details»
Everest Medicines Commences Operations at its mRNA Vaccine
Dec 28, 2022 --Everest owns complete pharmaceutical and vaccine value chain from discovery, clinical development, manufacturing and commercialization-- --Localizes company's mRNA …See details»
Everest Medicines Enters into Comprehensive Agreements with …
SHANGHAI, Sept. 13, 2021 /PRNewswire/ -- Everest Medicines Limited (HKEX 1952.HK, "Everest" or the "Company") announced today two separate definitive agreements …See details»